Cost-effectiveness of adjuvant chemotherapy with uracil-tegafur for curatively resected stage III rectal cancer.
about
Extrapolating Survival from Randomized Trials Using External Data: A Review of MethodsEconomic studies in colorectal cancer: challenges in measuring and comparing costs.Cost-minimization analysis of adjuvant chemotherapy regimens given to patients with colorectal cancer in JapanThe peculiar economics of life-extending therapies: a review of costing methods in health economic evaluations in oncology.Protective effects of water-soluble low-molecular-weight beta-(1,3-1,6)d-glucan purified from Aureobasidium pullulans GM-NH-1A1 against UFT toxicity in mice.
P2860
Cost-effectiveness of adjuvant chemotherapy with uracil-tegafur for curatively resected stage III rectal cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Cost-effectiveness of adjuvant ...... ected stage III rectal cancer.
@en
type
label
Cost-effectiveness of adjuvant ...... ected stage III rectal cancer.
@en
prefLabel
Cost-effectiveness of adjuvant ...... ected stage III rectal cancer.
@en
P2093
P2860
P356
P1476
Cost-effectiveness of adjuvant ...... ected stage III rectal cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604666
P407
P577
2008-09-16T00:00:00Z
P5875
P6179
1005571904